Senior insider sale
Chief Scientific Officer at MEREO BIOPHARMA GROUP PLC — senior position signals high conviction
$159.7K
40.37K shares
What this filing means
LEWICKI JOHN A. plans to sell 40.37K shares of MEREO BIOPHARMA GROUP PLC valued at approximately $159.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2024ACC: 0000950170-24-105907
Officer· Chief Scientific Officer
Since Feb 2026
40.37K
Shares to sell
$159.7K
Approx. market value
46K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Same Day Cashless Exercise and Sale
Equity Compensation
9/12/2024
46KTotal acquired46K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/12/2024 | Same Day Cashless Exercise and Sale Equity Compensation | 46K | — |
| Total | 46K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
16.81K
Market value
$57.0K
6/26/2024
—Completed
Units to sell
7.42K
Market value
$27.4K
6/25/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.15K
Market value
$75.3K
9/12/2024
Total
Units
40.37K
Value
$159.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/26/2024 | 16.81K | $57.0K | — | Completed |
6/25/2024 | 7.42K | $27.4K | — | Completed |
| Planned — Approximate Date | ||||
9/12/2024 | 16.15K | $75.3K | NASDAQ | Planned |
| Total | 40.37K | $159.7K | ||